MedPath

Culinary Spices in Metabolic Syndrome.

Not Applicable
Completed
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: Culinary spices
Registration Number
NCT06423248
Lead Sponsor
United Arab Emirates University
Brief Summary

This double blind, placebo controlled randomized controlled trial aims to evaluate the effect of three commonly used culinary spices - ginger (Zingiber officinale), cinnamon (Cinnamomum) and black seed (Nigella sativa) on the cardiometabolic parameters of individuals with risk factors of metabolic syndrome. Participants consume their assigned treatment for 12 weeks, and key cardiovascular and glucometabolic parameters are recorded at baseline, week 6, and week 12 of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • age (18-50 years)
  • 2 or more of MetS diagnostic criteria:
  • high waist circumference (>80 cm for female and >94 cm for males),
  • elevated blood pressure (equal to or greater than 130/85 mm Hg or use of medication for hypertension),
  • high fasting blood glucose (equal to or greater than 100 mg/dL [5.6 mmol/L] or use of medication for hyperglycemia),
  • lowered HDL cholesterol (less than 40 mg/dL [1.03 mmol/L] for men and less than 50 mg/dL [1.29 mmol/L] for women) and
  • increased triglycerides (equal to or greater than 150 mg/dL [1.7 mmol/L]). Participants who had at least three risk factors out of five or had two risk factors and one borderline were included in the study.

Exclusion Criteria

  • older than 50 years old or younger than 17 years old and
  • did not meet the metabolic syndrome diagnostic criteria
  • allergic to spices
  • current smokers
  • pregnant women
  • lactating women or
  • currently taking medication and if they
  • refused to provide blood sample.
  • acute illnesses
  • chronic diseases such as kidney, liver, cardiovascular and gastrointestinal diseases were excluded from the study
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GingerCulinary spicesParticipants consumed 3g of dried powdered Ginger (Zingiber officinale) daily for 12 weeks.
Black SeedCulinary spicesParticipants consumed 3g of dried powdered Black Seed (Nigella sativa) daily for 12 weeks.
PlaceboCulinary spicesParticipants consumed 3g of powdered corn starch daily for 12 weeks.
CinnamonCulinary spicesParticipants consumed 3g of dried powdered Cinnamon (Cinnamomum) daily for 12 weeks.
Primary Outcome Measures
NameTimeMethod
Mean Change in Fasting Blood Glucose at 12 weeksBaseline, Week 6 and Week 12

Fasting plasma glucose blood test taken at baseline, week 6 and week 12.

Mean Change in HbA1c at 12 weeksBaseline, Week 6 and Week 12

Glycated Haemoglobin blood test taken at baseline, week 6 and week 12.

Secondary Outcome Measures
NameTimeMethod
Mean Change in Weight at 12 weeksBaseline, Week 6 and Week 12

Weight taken at baseline, week 6 and week 12.

Mean Change in Body Mass Index at 12 weeksBaseline, Week 6 and Week 12

Weight taken at baseline, week 6 and week 12, and BMI calculated as weight divided by height squared.

Mean Change in Densitometric Body Composition at 12 weeksBaseline, Week 6 and Week 12

Dual Energy Xray Absorptiometry performed at baseline, week 6 and week 12, and Fat mass, body fat percentage, visceral fat, fat free mass, and skeletal muscle mass calculated.

Mean Change in Blood Pressure at 12 weeksBaseline, Week 6 and Week 12

Systolic and diastolic blood pressure taken at baseline, week 6 and week 12.

Mean Change in LDL Cholesterol at 12 weeksBaseline, Week 6 and Week 12

Low Density Lipoprotein Blood Test taken at baseline, week 6 and week 12.

Mean Change in Triglyceride concentrations at 12 weeksBaseline, Week 6 and Week 12

Triglyceride Blood Test taken at baseline, week 6 and week 12.

Mean Change in Waist Circumference at 12 weeksBaseline, Week 6 and Week 12

Waist Circumference taken at baseline, week 6 and week 12.

Mean Change in Waist to Hip ratio at 12 weeksBaseline, Week 6 and Week 12

Waist and Hip Circumference taken at baseline, week 6 and week 12, and Waist-Hip ratio calculated.

Mean Change in Total Cholesterol at 12 weeksBaseline, Week 6 and Week 12

Total Cholesterol Blood Test taken at baseline, week 6 and week 12.

Mean Change in HDL Cholesterol at 12 weeksBaseline, Week 6 and Week 12

High Density Lipoprotein Blood Test taken at baseline, week 6 and week 12.

Trial Locations

Locations (1)

United Arab Emirates University

🇦🇪

Al Ain, Abu Dhabi, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath